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Abstract
Background As outcome data for prune belly syndrome
(PBS) complicated by end-stage renal disease are scarce, we
analyzed characteristics and outcomes of children with PBS
using the European Society for Pediatric Nephrology/
European Renal Association-European Dialysis and
Transplant Association (ESPN/ERA-EDTA) Registry data.
Methods Data were available for 88 male PBS patients aged
<20 years who started renal replacement therapy (RRT) be-
tween 1990 and 2013 in 35 European countries. Patient char-
acteristics, survival, and transplantation outcomes were com-
pared with those of male patients requiring RRT due to con-
genital obstructive uropathy (COU) and renal hypoplasia or
dysplasia (RHD).
Results Median age at onset of RRT in PBS was lower [7.0;
interquartile range (IQR) 0.9–12.2 years] than in COU (9.6;
IQR: 3.0–14.1 years) and RHD (9.4; IQR: 2.7–14.2 years).
Unadjusted 10-year patient survival was 85% for PBS, 94%
for COU, and 91% for RHD. After adjustment for country,
period, and age, PBS mortality was similar to that of RHD but
higher compared with COU [hazard ratio (HR) 1.96, 95%
confidence interval (CI) 1.03–3.74]. Seventy-four PBS pa-
On behalf of the ESPN WG CAKUT/UTI/ bladder dysfunction
* Marjolein Bonthuis
m.bonthuis@amc.uva.nl
1 Department of Pediatric Nephrology, Ankara University Faculty of
Medicine, Ankara, Turkey
2 ESPN/ERA-EDTA Registry, Department of Medical Informatics,
Academic Medical Center, University of Amsterdam, Amsterdam
Public Health research institute, Amsterdam, The Netherlands
3 Department of Biostatistics, Ankara University School of Medicine,
Ankara, Turkey
4 Spaarne Gasthuis Academie, Spaarne Gasthuis,
Hoofddorp, The Netherlands
5 Department of Pediatrics, Belarusian State Medical University,
Minsk, Belarus
6 Department of Pediatrics, Division of Pediatric Nephrology,
University Hospital, Lausanne, Switzerland
7 Department of Paediatric Nephrology, Royal Hospital for Sick
Children, Glasgow, UK
8 Pediatric Nephrology and Dialysis Unit, Department of Clinical
Sciences and Community Health, University of Milan Fondazione
IRCCS Cà Granda, Ospedale Maggiore Policlinico Via della
Commenda, 9, 20122 Milan, Italy
9 Children’s Hospital University of Helsinki, Helsinki, Finland
10 Department of Nephrology, Rigshospitalet, Copenhagen University
Hospital, Copenhagen, Denmark
11 Department of Paediatric Nephrology, Armand-Trousseau Hospital,
APHP, Paris, France
12 University Pierre and Marie Curie, Paris, France
13 Dialyisis Unit, Paediatric Nephrology and Dialysis Department,
IRCCS Giannina Gaslini, Genoa, Italy
14 University Children’s Hospital Marburg, Philipps-University,
Marburg, Germany
15 Pediatric Nephrology Unit, Bordeaux University Hospital,
Bordeaux, France
16 Department of Pediatric Nephrology, University Children’s Hospital
Heidelberg, Heidelberg, Germany
17 Department of Pediatric Nephrology, Emma Children’s Hospital,
Academic Medical Center, Amsterdam, The Netherlands
Pediatr Nephrol (2018) 33:117–124
DOI 10.1007/s00467-017-3770-9
tients (84%) received a first kidney transplant after a median
time on dialysis of 8.4 (IQR 0.0–21.1) months. Outcomes
with respect to time on dialysis before transplantation, chance
of receiving a first transplant within 2 years after commencing
RRT, and death-censored, adjusted risk of graft loss were sim-
ilar for all groups.
Conclusions This study in the largest cohort of male patients
with PBS receiving RRT to date demonstrates that outcomes
are comparable with other congenital anomalies of the kidney
and urinary tract, except for a slightly higher mortality risk
compared with patients with COU.
Keywords Prune belly syndrome . Children . Renal
replacement therapy . Transplantation . Dialysis
Introduction
Prune belly syndrome (PBS) is a very rare congenital disorder
that consists of a deficiency in the development of anterior
abdominal wall muscles, variable amounts of urinary tract
dilatation, and cryptorchidism. Other fetal malformations that
may be associated with PBS include gastrointestinal, cardiac,
pulmonary, and limb abnormalities [1]. Prenatal ultrasound
features might include oligo- or anhydramnios, megacystis,
hydronephrosis, and hyperechogenic kidneys [2]. The inci-
dence is 3.8/100,000 live births, and >95% of patients are
boys [3]. Reports of more than one PBS case in the same
family have suggested a genetic contribution. Although sev-
eral gene loci have been defined, a clear genetic basis for PBS
has not yet been established [4–7]. It is thought that PBS arises
from a defect in the intermediate and lateral plate mesoderm
development during the 6th to 10th week of gestation,
resulting in clinical abnormalities [2, 8].
PBS is a clinical entity with a wide spectrum of severity;
approximately 10–25% of newborn infants die in the perinatal
period, and nearly a third of PBS patients outside the postnatal
period will develop end-stage renal disease (ESRD) requiring
renal replacement therapy (RRT) [9, 10]. Causes of ESRD are
congenital renal dysplasia, lower urinary tract obstruction,
and/or infection. These are similar to causes of ESRD seen
in other congenital anomalies of the kidney and urinary tract
(CAKUT), yet PBS has generally been associated with ad-
verse outcomes in children on RRT [1]. However, reliable data
on outcomes in these patients are lacking.
We aimed to describe the incidence, clinical, and demo-
graphic characteristics of boys with PBS requiring RRT using
the European Society of Pediatric Nephrology/European
Renal Association–European Dialysis and Transplant
Association (ESPN/ERA–EDTA) Registry. In addition,
long-term outcomes of PBS patients who started RRT
between 1990 and 2013 were assessed and compared with
male controls undergoing RRT for congenital obstructive
uropathy (COU) and congenital renal hypodysplasia and
dysplasia (RHD).
Methods
Study population
As PBS almost exclusively affects boys, girls were excluded
from analyses. Patient data were extracted from the ESPN/
ERA-EDTA Registry, a population-based cohort study. On
an annual basis, the Registry collects individual patient data
on all European children starting RRT, including date of birth,
sex, primary renal disease, date and treatment modality at start
of RRT, all subsequent changes in treatment modalities, and
date and cause of death. Furthermore, data for several clinical
parameters such as height and serum creatinine are collected
for some countries [11].
The ERA-EDTA coding system for renal diseases was used
to identify male patients with PBS [12] from 35 countries who
started RRT at <20 years of age between January 1990 and
December 2013. Two different groups of patients with other
congenital causes of renal disease who commenced RRT in
the same period served as controls: C(1) male patients with
COU with or without vesicoureteric reflux and (2) those with
congenital RHD. Table 1 describes participating countries and
respective periods of follow-up. Additionally, we performed a
sensitivity analysis comparing outcomes of PBS patients with
those of glomerulonephritis patients on RRT. This sensitivity
analysis did not yield any statistically significant differences
in patient survival, access to transplantation, and graft survival
between PBS and glomerulonephritis patients.
Height values were normalized to Z-scores for age and sex
using recent national growth charts or growth charts for north-
ern or southern European countries [13]. Estimated glomeru-
lar filtration rate (eGFR) was calculated using the bedside
Schwarz formula [14].
Statistical analysis
To ensure complete coverage, incidence and prevalence of RRT
for PBS were calculated for children <15 years of age and
expressed per 100 million of the age-related population.
General population data were derived from the Statistical
Office of the European Communities (EUROSTAT) [15].
Only countries contributing data over the entire follow-up period
(1990–2013) were included when calculating mean yearly inci-
dence, as was the case for analyses of comparisons over time.
Differences in patient characteristics between groups were ex-
amined using chi-square tests for categorical and Kruskal–
Wallis test for continuous parameters. Patient and peritoneal
dialysis (PD) technique survival rates were determined using
the Kaplan–Meier method (unadjusted survival) and Cox
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proportional hazards frailty analyses (adjusted survival), includ-
ing country as a random effect to account for clustering of pa-
tients within the same country. Causes of death were coded
according to the ERA-EDTA coding system [12]. PD technique
survival was defined as technique failure or switch to hemodi-
alysis (HD), and patients were censored at the time of transplan-
tation or death. Death was considered a competing event in
access to transplantation and graft survival analyses, and a cu-
mulative incidence competing risk method was used [16]. For
patients with a pre-emptive kidney transplant, the time between
start of RRT and transplantation was set to 0. Patients were
followeduntil theywere lost to follow-up,when reaching20years
of age, or at the end of study (31 December 2013), whichever
occurred first. Analyses were adjusted for country and age at
onset and period of RRT. All statistical analyses were performed
in SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Incidence and prevalence
Data were obtained on 2120 male patients. Of these, 88 (4.2%)
had PBS, while 904 (42.6%) patients with COU and 1128
(53.2%) with RHD served as controls. PBS patients were iden-
tified in 17 countries (Table 1). Within countries with complete
follow-up, the average yearly incidence of RRT for PBS in boys
<15 years was 15.6 per 100 million age-related population in
1990–2013; point prevalence on 31 December 2013 of RRT for
those boys was 68 per 100 million.
Patient characteristics
Median age at onset of RRTwas 7.0 [interquartile range (IQR)
0.9–12.2] years in PBS, i.e. significantly lower compared with
patients with COU (9.6; IQR: 3.0–14.1 years) and RHD (9.4;
IQR: 2.7–14.2 years) (p = 0.02). In age groups <6 months and
between 6 and 10 years of age, a higher percentage of patients
started RRT due to PBS than to COU or RHD (Fig. 1). Height
Z-score and eGFR at start of RRTof PBS patients were similar
to controls (Table 2).
Among countries with complete follow-up (n = 1465),
comparison between the 1990–2000 and the 2001 and 2013
cohort, there was a trend towards starting RRTat younger ages
among PBS and COU patients but not in RHD patients (Fig.
2). In the RHD group, there was a shift over time to older ages
at RRT onset.
The most frequent treatment modality when commencing
RRT for PBS was PD (50%), followed by renal transplanta-
tion (33%) and HD (17%) (Table 2). Distribution of treatment
Table 1 Number of patients with prune belly syndrome and controls by
country
Country (period) Prune belly
syndrome
Congenital
obstructive
uropathy
Renal hypo- or
dysplasia
Austria
(1990–2013)
2 22 30
Belarus
(2008–2013)
2 7 5
Belgium
(1993–2013)
1 0 9
Croatia
(1990–2013)
1 14 3
Denmark
(1990–2013)
1 24 15
Finland
(1990–2013)
3 28 12
France
(2004–2013)
6 72 156
Greece
(1990–2013)
1 23 52
Italy (1994–2013) 9 1 0
Poland
(2006–2013)
1 36 36
Portugal
(2006–2013)
2 15 14
Spain
(1990–2013)
13 119 43
Sweden
(1990–2013)
4 0 58
Switzerland
(1990–2013)
2 4 55
The Netherlands
(1990–2013)
6 61 103
Turkey
(2010–2013)
2 5 5
United Kingdom
(1990–2013)
32 329 353
Other countries1 0 144 179
Total 88 904 1128
1Albania (2010–2013), Bulgaria (2008–2013), Czech Republic (1990–
2013), Estonia (2007–2013), FYR of Macedonia (2006–2013), Georgia
(2013), Germany (2010–2013), Hungary (2006–2013), Iceland (1990–
2013), Lithuania (2006–2013), Montenegro (2007–2009), Norway
(1990–2013), Romania (2006–2013), Russia (2006–2013), Serbia
(2006–2013), Slovakia (2007–2013), Slovenia (2006–2013) and
Ukraine (2010–2012)
Fig. 1 Age distributions of patients at the onset of renal replacement
therapy (RRT)
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modalities when commencing RRTwas similar in PBS when
compared with controls.
Patient survival
During the observation period, 111 patients died, nine of
whom had PBS. Causes of death of PBS patients were similar
to those of controls. Infection was the most frequent known
cause of death (44% PBS, 42% COU, 20% RHD) (Table 3).
Among PBS patients, the overall 1-year survival was
86.7%, 100%, and 100% at ≤1 year, 1–12 years, and >12 years
at start of RRT, respectively; 5-year survival rates were 86.7%,
100%, and 80.0%, respectively; overall 10-year survival rates
were 85% for PBS, 94% for COU, and 91% for RHD.
Unadjusted survival since start of RRT (Fig. 3A) and accord-
ing to chronological age (Fig. 3b) differed significantly be-
tween groups.
Mortality risk of PBS patients was significantly higher than
those with COU [hazard ratio (HR) 2.27; 95% confidence
interval (CI) 1.30–3.98] but similar to patients with congenital
RHD (HR 1.48; 95% CI 0.70–3.14). Adjusting for country,
age, and period of RRT did not change these associations
[adjusted HR (aHR) PBS vs. COU 2.21; 95% CI 1.03–4.77;
aHR PBS vs. RHD 1.46; 95% CI 0.70–3.07].
PD technique survival
Of the 873 patients who started RRT on PD, 103 (eight PBS,
44 COU, 51 RHD) experienced technique failure or switched
to HD after a median of 1.2 (IQR 0.7–2.4) years on PD. One-
year technique survival was 92.1%, 93.1%, and 93.7% for
PBS, COU, and RHD patients, respectively. Age, country,
and period-adjusted risk of PD failure was not significantly
different between groups (aHR PBS vs. COU 1.17, 95% CI
0.50–2.72; aHR RHD vs. COU 0.97, 95% CI 0.76–1.24).
Transplantation
During the follow-up period, 74 (84.1%) PBS patients re-
ceived a first kidney transplant at a median age of 9.3 years
(IQR 4.7–13.2). The median time on dialysis before first kid-
ney transplantation was 8.4 months (IQR 0.0–21.1), whereas
29 (33.0%) patients received a pre-emptive kidney graft. Time
spent on dialysis before transplantation was similar in PBS
and control groups (Table 4), as was the chance of receiving
a first kidney transplant (aHR 1.00; 95% CI 0.78–1.29).
Most patients received a kidney from a deceased donor,
with little difference between PBS and controls (60.8%,
62.4%, and 58.3% in PBS, COU, and RHD, respectively).
Table 2 Clinical and demographic characteristics of patients at the start of renal replacement therapy
Prune belly syndrome
(n = 88)
Congenital obstructive uropathy
(n = 904)
Congenital renal hypo−/dysplasia
(n = 1128)
P value*
Height (z-scores) -1.69 (−3.29 to −0.67)
n = 48
−1.88 (−2.76 to −0.94)
n = 485
−1.88 (−2.85 to −1.04)
n = 516
0.65a
eGFR 8.61 (6.61–11.00)
n = 35
8.18 (6.39–10.30)
n = 354
8.18 (5.97– 10.64)
n = 437
0.78a
Age 7.0 (0.9–12.2) 9.6 (3.0–14.1) 9.4 (2.7– 14.2) 0.02a
Age groups n (%)
< 0.5 years 15 (17.1%) 77 (8.5%) 120 (10.6%) 0.04b
0.5–5 years 25 (28.4%) 253 (28.0%) 288 (25.5%)
6–10 years 22 (25.0%) 183 (20.2%) 250 (22.2%)
≥11 years 26 (29.5%) 391 (43.3%) 470 (41.7%)
RRT periods n (%)1
1990–1999 32 (49.2%) 312 (48.6%) 298 (39.3%) 0.002b
2000–2013 33 (50.8%) 330 (51.4%) 460 (60.7%)
Initial RRT modality n (%)
HD 15 (17.1%) 236 (26.1%) 287 (25.4%) 0.21b
PD 44 (50.0%) 377 (41.7%) 452 (40.1%)
Tx 29 (33.0%) 277 (30.6%) 363 (32.2%)
Missing 0 (0%) 14 (1.6%) 26 (2.3%)
Medians (interquartile range) are given for continuous variables; frequencies and percentages are given for categorical variables
eGFR estimated glomerular filtration rate, RRT renal replacement therapy, HD hemodyalisis, PD peritoneal dialysis, Tx transplantation
1Among countries with complete coverage over the entire follow-up period (Austria, Croatia, Denmark, Finland, Greece, Iceland, Norway, Spain,
Sweden, Switzerland, The Netherlands, United Kingdom)
*P values are based on Kruskal-Wallis testa and chi-square testb
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Five PBS patients (6.8%) and 153 (9.4%) controls received
two or more transplants during follow-up. Competing risk
analysis demonstrated that PBS patients had a similar likeli-
hood of receiving their first kidney transplant within 2 years
after commencing RRT (65%) as controls: 71% in COU and
68% in RHD. Within 5 years, this was 87% in PBS, 88% in
COU, and 85% in RHD. Unadjusted 5- and 10-year graft
survival was 86.2% and 78.4% in PBS, 86.5% and 75.9% in
COU, and 87.0% and 74.5% in RHD, respectively. After ad-
justment for country, age at and period of transplantation,
death-censored risk of graft loss was not significantly different
between PBS and COU patients (aHR 0.94, 95% CI 0.53–
1.66) or RHD (aHR 0.91, 95% CI 0.51–1.62). Similar results
were obtained when death was included as graft failure event.
Discussion
In this study, we provide an analysis of the largest reported
cohort to date of PBS patients— 88 boys <20 years when
commencing RRT—and showed that outcomes were better
than previously reported. PD technique and graft survival
rates were similar to boys on RRT due to other forms of
Fig. 2 Age at renal replacement
therapy (RRT) onset over the two
time periods. Only countries with
complete follow-up are included
in the analyses. Dotted lines indi-
cate median age [interquartile
range (IQR)] at start of RRT
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CAKUT. Patient survival of male PBS patients was similar to
that of male RHD patients but significantly lower than males
on RRT due to COU.
Median age at start of RRTwas significantly lower in boys
with PBS (7.0 years) compared with those with COU
(9.6 years) and RHD (9.4 years). The relatively high incidence
in patients <6 months can possibly be attributed to significant
renal dysplasia, while the later peak, between 6 and 10 years,
is hypothesized to occur due to additional renal damage
caused by repeated infections or high pressures generated
from obstruction. This clinical information has not been re-
ported to the Registry. Nearly 45% of patients with COU
started dialysis after 10 years of age, whereas >40% of PBS
patients needed dialysis before 5 years of age, including al-
most 20% who started within the first 6 months of life, sug-
gesting that severity of dysplasia rather than obstruction plays
the most important role in the pathogenesis and predominantly
determines the renal outcome of PBS patients.
In the past 25 years, there was a trend over time toward a
decreased age at start of RRT in patients with PBS. The higher
proportion of very young patients in the last decade may re-
flect the increasing acceptance of infants into RRT programs
and increased awareness of the disease. The overall 85% 10-
year patient survival rate in PBS patients on RRT was rather
good and similar to those with RHD but slightly worse com-
pared with COU. However, it should be noted that PBS pa-
tients entering RRT programs probably are the ones with more
favorable prognosis. Conversely, PBS is associated with se-
vere comorbidities that may affect survival on RRT; only lim-
ited information on comorbidities is available from the
Registry. Causes of death in our study were similar in all
groups, with infection being the most frequent cause; fewer
patients died of cardiovascular causes. As the presence of
severe renal dysfunction and pulmonary hypoplasia results
in mortality in nearly all PBS patients within a short time,
infants who survive frequently have adequate urine pro-
duction, which might protect them from fluid overload,
hypertension, and other cardiovascular problems [17,
18]. Nevertheless, our study clearly demonstrates that sur-
vival of PBS patients on RRT is encouraging, and RRT
should be offered to PBS patients, including infants.
We encountered no restrictions to performing PD in
boys with PBS due to hypoplasia of the abdominal wall
musculature. PD frequency as the initial treatment modal-
ity and PD technique survival were similar for PBS, COU,
and RHD patients.
Renal transplantation appears as the best treatment option
for PBS patients with ESRD [18, 19]. A few single-center
studies have assessed the outcome of renal transplantation in
children with PBS; most were retrospective, deceased-donor
Table 3 Number and causes of deaths in the study population
Prune belly
syndrome
(n = 88)
Congenital
obstructive
uropathy
(n = 904)
Congenital renal
hypo/dysplasia
(n = 1128)
Death 9 (10.2%) 36 (4.0%) 66 (5.9%)
Cause of Death
Fluid overload/
pulmonary
edema
0 (0%) 0 (0%) 3 (4.5%)
Hemorrhage 0 (0%) 1 (2.8%) 1 (1.5%)
Cardiac arrest 1 (11.1%) 3 (8.3%) 6 (9.1%)
Cerebrovascular
accident
0 (0%) 0 (0.0%) 3 (4.5%)
Infections 4 (44.4%) 15 (41.7%) 13 (19.7%)
Malignancies 0 (0%) 0 (0%) 5 (7.6%)
Uremia caused by
graft failure
0 (0%) 0 (0%) 4 (6.1%)
Other known 2 (22.2%) 11 (30.6%) 15 (22.7%)
Treatment withdrawal 2 (22.2%) 2 (5.6%) 3 (4.5%)
Unknown/missing 0 (0.0%) 4 (11.1%) 13 (19.7%)
Fig. 3 Unadjusted survival of patients with prune belly syndrome (PBS)
and control groups according to time on renal replacement therapy (RRT)
(a) and according to chronological age (b)
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transplant reports on a small number of cases ranging from
five to nine patients [9, 20, 21]. Our study involved 74 chil-
dren and 81 grafts (30% living donors) with a median follow-
up of >5 years. Accordingly, this is the first large, population-
based study providing comprehensive information on timing
and outcomes of transplantation in PBS. Median age at trans-
plantation was 9.3 years—comparable with previous reports
[9, 20, 22]. Time spent on dialysis before transplantation was
similar in PBS and control groups, as was the chance of re-
ceiving a first renal transplant. In addition, 65% of PBS pa-
tients had their first kidney transplant within 2 and 87%within
5 years after commencing dialysis; one third received a pre-
emptive kidney graft. Reinberg et al. [21] found that patients
with PBS waited a shorter period for transplantation than con-
trols and suggested that the distensible abdominal wall char-
acteristic of the syndrome permits placement of an adult kid-
ney in a young child. Previous reports have compared the
outcome of transplanted PBS patients with the outcome of
age-matched controls, including or excluding patients with a
dysfunctional lower urinary tract or a nondiabetic cause of
ESRD [20–22]. Five-year graft survival rates reported by
Fontaine et al. [22] [22], Fusaro et al. [9], and Kamel et al.
[20] were 50%, 67%, and 73%, respectively, and were similar
to control groups. We found remarkably better graft survival
in our cohort, with 5- and 10-year survival rates in PBS of
86% and 78%, respectively.
To the best of our knowledge, we provide the first compre-
hensive information on outcomes of the largest population-
based cohort of PBS patients requiring RRT to date.
However, some limitations need to be acknowledged. Due to
the nature of the Registry, including only children on RRT,
our data underestimate the true incidence of PBS in Europe
and results only apply to male PBS patients on RRT. The
severity of urinary tract abnormalities in PBS patients and
rate of urinary tract infections and surgical management are
not reported to the Registry and could therefore not be studied.
Furthermore, detailed information on comorbidities was not
available. In addition, a major fraction of patients in the COU
group most likely had posterior urethral valves (PUV), as it is
the most common obstructive uropathy in boys leading to
ESRD. However, because of the lack of detail in primary renal
disease coding, we cannot fully ensure that all COU patients
had PUV.
Conclusions
In conclusion, in this Europe-wide study of boys with
PBS on RRT, we demonstrate that outcomes are similar
to those of patients on RRT due to other forms of
CAKUT. Graft and overall survival of PBS patients are
encouraging, suggesting that RRT should be offered to all
PBS patients similarly to that offered to patients with other
forms of CAKUT.
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